Continuum Advisory, LLC Natera, Inc. Transaction History
Continuum Advisory, LLC
- $680 Million
- Q2 2024
A detailed history of Continuum Advisory, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 249 shares of NTRA stock, worth $32,646. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249
Previous 332
25.0%
Holding current value
$32,646
Previous $30,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NTRA
# of Institutions
504Shares Held
120MCall Options Held
412KPut Options Held
270K-
Vanguard Group Inc Valley Forge, PA11.3MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$888 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY6.07MShares$795 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY5.26MShares$690 Million2.83% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.46MShares$585 Million2.34% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...